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Increased levels of serum adhesion molecules have recently been detected in patients with or at risk of developing atherosclerosis [10] [11] [12] . Increased levels of E-selectin, ICAM-1 and VCAM-1 have also been found in patients with insulin-dependent diabetes and non-insulin-dependent diabetes (NIDDM) [10, [13] [14] [15] but it is still unclear whether this increase is related to glycaemic control. In poorly controlled diabetic patients, excess glucose causes enhanced glycation of plasma proteins. This non-enzymatic glycation of proteins has been presumed to cause an enhanced oxidative stress, through generation of oxygen free radicals [16] [17] [18] [19] . An enhanced oxidative stress, i. e. increased levels of plasma hydroperoxides, has actually been observed in NIDDM [20] [21] [22] [23] [24] . The augmented generation of free radicals could also result in oxidative damage of LDL, the known potentially atherogenic properties of oxidized LDL including monocyte recruitment [25] and modulation of expression of adhesion molecules [26, 27] . Enhanced susceptibility of LDL to oxidation has recently been reported in diabetic patients [24, 28, 29] .
The present study analyses the relationship of glycaemic control to concentrations of E-selectin, VCAM-1 and ICAM-1 in NIDDM patients. The study also addresses whether glycaemic control can affect the oxidative stress, and hence adhesion molecule plasma concentrations, in NIDDM patients.
Patients and methods
Patients. Thirty-four NIDDM patients in poor metabolic control were studied. The subjects (19 males and 15 females) with a mean history of diabetes of 9.5 ± 4.7 years, had a mean age of 57.5 ± 10.2 years and a body mass index (BMI) calculated from weight/height 2 of 29.2 ± 5.1 kg/m 2 . All participants reported only occasional alcohol intake; of the 34 patients only 3 reported occasionally smoking (not more than 2 cigarettes for the study period); in addition, it was ascertained that they had no renal impairment, liver disease, clinical symptoms of coronary artery disease and peripheral artery disease, hyperlipidaemia or pathological processes known to increase adhesion molecules. Informed written consent was obtained from all participants. At the time of examination, details of blood pressure and use of hypotensive medications were recorded. Fourteen NIDDM patients had hypertension and were under treatment with calcium antagonists and angiotensin-converting enzyme inhibitors. All subjects were advised to consume a lipid-lowering diet before their admission to the study. The diet was isocaloric and contained 25 % of energy as fat, 15 % of energy as protein and 60 % of energy as carbohydrate (80 % as complex carbohydrates). The ratio of polyunsaturated to saturated fatty acids was 0.5. The dietary compliance was monitored during the treatment period by a specially trained dietician who collected 3-day diet histories and 2-week daily dietary records every 15 days as previously described [30] .
Twenty-four patients were treated either with anti-diabetic oral sulphonylureas alone (n = 6), in combination with metformin (n = 15) or with insulin (n = 3); 7 patients were treated with three daily insulin injections and 3 patients had no antidiabetic medication. Fasting plasma and lipoprotein lipids, glucose, glycated haemoglobin (HbA 1C ), susceptibility of LDL to oxidation, plasma hydroperoxides and adhesion molecules (E-selectin, VCAM-1 and ICAM-1) were evaluated at the beginning of the study and after 90 days of dietary and pharmacological treatment. Fasting plasma glucose was also monitored every 4 weeks during the 90-day treatment regimen.
Methods. Whole blood was collected into vacutainer tubes containing ethylendiamine tetraacetic acid (EDTA) (1 mg/ml) and immediately centrifuged at 2000 rev/min for 20 min at 4°C. Plasma was stored at 4°C and processed for lipoprotein separation within 1 day. Lipoproteins were isolated by sequential ultracentrifugation in NaBr solutions [31] containing 1 mg/ ml EDTA, stored at 4°C and used within 4 days. Cholesterol and triglycerides in plasma and lipoprotein fractions were determined by Technicon autoanalyser II methodology [32, 33] . Glucose in plasma was measured by the glucose oxidase method on the Beckman glucose analyser [34] . HbA 1C in plasma was measured by a minicolumn chromatographic procedure [35] .
The method evaluating the susceptibility of LDL to oxidation (expressed as lag phase in minutes) is based on development of fluorescence during copper-catalysed LDL oxidative modification, as described elsewhere [36] . Based on the fluorescence development from 0 to 260 min, the duration of the lag phase was calculated as described previously [36] .
Plasma hydroperoxides were measured as the thiobarbituric acid adduct, by a published high performance liquid chromatography (HPLC) method [37, 38] . Analytical separations were performed with a Hewlett-Packard 1050 connected to a reverse phase C18, 15 × 0.46 cm (Bio-Rad, Hercules Calif., USA); the system included a guard column (Microguard System, Bio-Rad), with a Hewlett-Packard spectrophotometric UV-VIS detector at 532 nm (Boise, Idaho, USA). Malonyldialdehyde (MDA) standard was prepared by dissolving 220.3 mg of 1,1,3,3-tetraethoxypropane (Aldrich-Chemie, Steinheim, Germany) in 100 ml of deionized water, to give a 10 mmol/l stock solution.
Concentrations of soluble E-selectin, ICAM-1 and VCAM-1 were estimated using the soluble E-selectin, ICAM-1 and VCAM-1 ELISA kits (British Bio-technology Products Ltd, Abingdon-Oxon, UK), as previously described [15] . The assay is standardized against purified soluble forms of recombinant E-selectin, VCAM-1 and ICAM-1. The intra-assay coefficients of variation for all ELISA assays were less than 4 %.
Statistical analysis
Values are expressed as mean ± SD. Statistical differences between data obtained before and after treatment were tested using Student's t-test for paired data. This test was applied after the distribution of the differences of each investigated parameter was demonstrated to be normal by means of the Kolmogorov-Smirnov one-sample test [39] . The relationships among the considered variables were studied using linear partial and multiple correlation analysis as previously described [40, 41] . Parameters were estimated by using the Systat program and manual for Macintosh (Systat Inc., Evanston, Ill., USA). The method used by Systat is called 'ordinary least squares', a method that minimizes the sum of the squared residuals. The R is the multiple Pearson correlation coefficient. Significance tests are based on the calculation of the 'standard error of estimate'. The significance of the entire model was tested employing the analysis of variance (F ratio).
The partial correlation of n independent variables given a dependent variable is the correlation between the residuals of each independent variable after each has been regressed on the dependent variable. Systat calculates the partial correlation by means of 'the residual correlation matrix'; it is the matrix of partial correlations among the y's given x.
Results
The anthropometric characteristics of the patients, as well as glucose concentration, percentage HbA 1C values and lipid profile at the beginning and at the end of the study are shown in Table 1 . After the 90 days of treatment, no significant variation in total plasma cholesterol, triglycerides, LDL cholesterol and HDL cholesterol was observed. HbA 1C and glucose concentrations were reduced from 7.4 ± 1.6 to 6.4 ± 1.3 % (p < 0.001) and from 9.7 ± 2.4 to 7.5 ± 1.7 mmol/l (p < 0.001), respectively. Table 2 shows the values of LDL lag phase, plasma hydroperoxides, E-selectin, VCAM-1 and ICAM-1 before and after treatment. The diet and the pharmacological treatment determined a significant increase in LDL lag phase (p < 0.0001) and a significant decrease in plasma hydroperoxides (p < 0.003). Among the adhesion molecules, only E-selectin was significantly decreased after the 90 days' treatment (p < 0.001). At the beginning of the study HbA 1C , LDL lag phase and plasma hydroperoxides were positively correlated with E-selectin (r = 0.51, p < 0.01; r = -0.57, p < 0.01; r = 0.54, p < 0.01, respectively) (Figs. 2-4) but not with VCAM-1 or ICAM-1. We found also a positive correlation of HbA 1C with LDL lag phase (r = 0.53, p < 0.01) and plasma hydroperoxides (r = 0.50, p < 0.01).
To evaluate the interrelationships among these variables, a multiple regression model was fitted to the data, using HbA 1C , LDL lag phase and plasma hydroperoxides as independent variables and E-selectin as a dependent variable. In particular in this study we applied the partial correlation analysis to the data. Data are mean ± SD corresponds to the variation (increase or decrease) of the average value of y when x 1 rises of one unit while the other x i remain constant. While, therefore, in multiple regression, several independent variables impact one dependent variable, in partial correlation analysis the correlation between a dependent (y) and an independent variable (x 1 ) is controlled for the other variables (x 2 ) of the multiple regression. Table 3 shows the simple and partial correlation coefficients between each of the independent variables (HbA 1C , LDL lag phase and plasma hydroperoxides) and the dependent variable (E-selectin). When the partial correlation analysis was applied and LDL lag phase and plasma hydroperoxides were kept constant, HbA 1C was no longer correlated with E-selectin (simple linear correlation coefficient = 0.51, p < 0.01; partial correlation coefficient = 0.12). The partial correlation coefficient of the LDL lag phase decreased to -0.51 (p < 0.01) (simple linear correlation coefficient = -0.57, p < 0.01), and the partial correlation coefficient of plasma hydroperoxides to 0.49 (p < 0.01) (simple linear correlation coefficient = 0.54, p < 0.01).
After 90 days' treatment the correlations between HbA 1C and E-selectin and between the parameters correlated with oxidative stress and E-selectin were lost.
The variations in each of the independent variables (HbA 1C , LDL lag phase and plasma hydroperoxides), however, correlated with those of the dependent variable (E-selectin) (r = 0.54, p < 0.01; r = -0.64, p < 0.01; r = 0.61, p < 0.01 respectively). Similarly, variations in HbA 1C correlated with those in LDL lag phase (r = 0.48, p < 0.01) and plasma hydroperoxides (r = 0.40, p < 0.01).
A multiple regression model for the evaluation of the correlation coefficients was also fitted to these data, using the variations in HbA 1C , LDL lag phase and plasma hydroperoxides as independent variables and the variation in E-selectin as a dependent variable (Table 4) . When the variations in LDL lag phase and plasma hydroperoxides were kept constant, the variation in HbA 1C was no longer correlated with that for E-selectin (simple correlation coefficient = 0.54, p < 0.01; partial correlation coefficient = 0.25). The partial correlation of LDL lag phase variation decreased to -0.51 (p < 0.01) (simple linear correlation coefficient = -0.64, p < 0.01), and the partial correlation of plasma hydroperoxides to 0.58 (p < 0.01) (simple linear correlation coefficient = 0.61, p < 0.01). 
Discussion
The results of this study show that the plasma concentration of E-selectin significantly decreased after a period of pharmacological and dietary treatment that induced an improvement of glycaemic control.
On the basis of the present results, assessing the mechanisms and the physiological significance, if any, of this decrease, is problematic. Since a correlation between HbA 1C and E-selectin plasma concentration was found, a first tentative explanation of our results may be that glycaemic control per se may, somehow, affect the plasma concentration of this adhesion molecule. These results are in agreement with our previous results, in which a correlation between HbA 1C and E-selectin was found in a small group of NIDDM patients [15] . Similar results were also obtained by Fasching et al. [42] in 159 NIDDM patients. Contrary to our [15] and Fasching's [42] results, in another recently published paper [14] , the levels of soluble adhesion molecules failed to correlate with glycaemic control. Actually soluble concentration of Eselectin was found in this study to be related not only to glycaemic control, i.e HbA 1C , but also to plasma hydroperoxides and to susceptibility of LDL to oxidation. To evaluate the interrelationships among these variables, a multiple regression model was fitted to the data, using HbA 1C , LDL lag phase and plasma hydroperoxides as independent variables and E-selectin as dependent variable. The analysis showed that the partial correlation coefficient with HbA 1C fell to non-significant values when it was controlled for the variables evaluated to assess oxidative stress. Although correlative analysis cannot be used to prove a causal relationship, the results suggest that oxidative stress more than glycaemic control may be a determinant of E-selectin plasma concentration. This conclusion is supported by the results we obtained after satisfactory metabolic control was achieved. Besides a reduction of soluble E-selectin concentration, the dietary and pharmacological treatment produced a significant decrease in plasma hydroperoxides and in LDL oxidation. The variation of HbA 1C was found to be correlated to the variation in E-selectin plasma concentration, as well as to the decrease in the parameters evaluated to assess oxidative stress. Also in this case, the fact that the variations in plasma hydroperoxides and LDL oxidation abolish the correlation between the variations in HbA 1C and soluble E-selectin, indicates that the influence of HbA 1C on E-selectin may be mediated.
In support of this view the results of this study also demonstrate that there was a positive correlation between HbA 1C with LDL lag phase and plasma hydroperoxides. Enhanced oxidative stress, as monitored by increased levels of plasma hydroperoxides [20] [21] [22] [23] [24] and increased susceptibility of LDL to oxidation, has already been reported in diabetic patients [24, 29] . In diabetic patients in poor control, excess glucose causes an enhancement of the glycation of plasma protein and this non-enzymatic glycation of proteins has been presumed to cause enhanced oxidative stress, through generation of oxygen free radicals [16] [17] [18] [19] . Byproducts of lipid peroxidation, such as conjugated dienes and thiobarbituric-acid-reactive substances, could therefore derive from the non-enzymatic glycation of proteins, generating oxygen free radicals. This mechanism may also affect the susceptibility of LDL to oxidation. The role of copper ions in the oxidative process of LDL is, in fact, to catalyse the conversion of trace amounts of preformed plasma hydroperoxides to alkoxy and peroxy radicals, which in turn initiate another round of lipid peroxidation [43] . Glycaemic control in NIDDM patients could therefore be related to E-selectin plasma concentration, through its effect on the parameters correlated to oxidative stress. In this context, exciting recent findings indicated that oxidized LDL and plasma hydroperoxides can affect the expression of adhesion molecules on endothelial cells in vitro [26, 27] . Additional evidence that the adhesion molecule expression on endothelial cells is an oxidative stress-responsive event comes from the inhibitory effects of various structural antioxidants in response to many different stimuli [27] . Glycaemic control could, therefore, affect soluble adhesion molecule concentration through its effect on oxidative stress; it is likely, in fact, that glycaemic control can favourably affect oxidative stress by reducing glycation and therefore free radical production [19] . The decrease of free radical production and the consequent fall in lipid peroxide generation can in turn reduce the expression of E-selectin on endothelial cells.
In conclusion, the results of this study show that there is a relationship between metabolic control and soluble E-selectin concentration; this relationship is mediated by the effect of glycaemic control on oxidative stress, which may affect endothelial cell activity.
